European Regulators Warn Of Anemia Drug Risks
Europe's drug regulating body has recommended that a class of anemia drugs often used to treat cancer patients update warning labels to say the drug could hasten the progression of cancer....To view the full article, register now.
Already a subscriber? Click here to view full article